SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Clinical trial NCT05568680 · RECRUITING
Trial details
- NCT number
- NCT05568680
- Sponsor
- Verismo Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-30
- Primary completion
- 2027-12-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.